Summary: A new study reveals how brain inflammation from infections and neurodegenerative diseases causes muscle weakness by releasing the IL-6 protein. Researchers found that IL-6 travels from the brain to muscles, reducing their energy production and function.
This discovery could lead to treatments for muscle wasting in diseases like Alzheimers and long COVID. Blocking the IL-6 pathway may prevent muscle weakness associated with brain inflammation.
Key Facts:
Source: WUSTL
Infections and neurodegenerative diseases cause inflammation in the brain. But for unknown reasons, patients with brain inflammation often develop muscle problems that seem to be independent of the central nervous system.
Now, researchers at Washington University School of Medicine in St. Louis have revealed how brain inflammation releases a specific protein that travels from the brain to the muscles and causes a loss of muscle function.
The study, in fruit flies and mice, also identified ways to block this process, which could have implications for treating or preventing the muscle wasting sometimes associated with inflammatory diseases, including bacterial infections, Alzheimers disease and long COVID.
The study is published July 12 in the journalScience Immunology.
We are interested in understanding the very deep muscle fatigue that is associated with some common illnesses, said senior authorAaron Johnson, PhD, an associate professor of developmental biology.
Our study suggests that when we get sick, messenger proteins from the brain travel through the bloodstream and reduce energy levels in skeletal muscle. This is more than a lack of motivation to move because we dont feel well. These processes reduce energy levels in skeletal muscle, decreasing the capacity to move and function normally.
To investigate the effects of brain inflammation on muscle function, the researchers modeled three different types of diseases anE. colibacterial infection, a SARS-CoV-2 viral infection and Alzheimers. When the brain is exposed to inflammatory proteins characteristic of these diseases, damaging chemicals called reactive oxygen species build up.
The reactive oxygen species cause brain cells to produce an immune-related molecule called interleukin-6 (IL-6), which travels throughout the body via the bloodstream. The researchers found that IL-6 in mice and the corresponding protein in fruit flies reduced energy production in muscles mitochondria, the energy factories of cells.
Flies and mice that had COVID-associated proteins in the brain showed reduced motor function the flies didnt climb as well as they should have, and the mice didnt run as well or as much as control mice, Johnson said.
We saw similar effects on muscle function when the brain was exposed to bacterial-associated proteins and the Alzheimers protein amyloid beta. We also see evidence that this effect can become chronic. Even if an infection is cleared quickly, the reduced muscle performance remains many days longer in our experiments.
Johnson, along with collaborators at the University of Florida and first author Shuo Yang, PhD who did this work as a postdoctoral researcher in Johnsons lab make the case that the same processes are likely relevant in people. The bacterial brain infection meningitis is known to increase IL-6 levels and can be associated with muscle issues in some patients, for instance.
Among COVID-19 patients, inflammatory SARS-CoV-2 proteins have been found in the brain during autopsy, and many long COVID patients report extreme fatigue and muscle weakness even long after the initial infection has cleared. Patients with Alzheimers disease also show increased levels of IL-6 in the blood as well as muscle weakness.
The study pinpoints potential targets for preventing or treating muscle weakness related to brain inflammation. The researchers found that IL-6 activates what is called the JAK-STAT pathway in muscle, and this is what causes the reduced energy production of mitochondria.
Several therapeutics already approved by the Food and Drug Administration for other diseases can block this pathway. JAK inhibitors as well as several monoclonal antibodies against IL-6 are approved to treat various types of arthritis and manage other inflammatory conditions.
Were not sure why the brain produces a protein signal that is so damaging to muscle function across so many different disease categories, Johnson said.
If we want to speculate about possible reasons this process has stayed with us over the course of human evolution, despite the damage it does, it could be a way for the brain to reallocate resources to itself as it fights off disease. We need more research to better understand this process and its consequences throughout the body.
In the meantime, we hope our study encourages more clinical research into this pathway and whether existing treatments that block various parts of it can help the many patients who experience this type of debilitating muscle fatigue, he said.
Yang S, Tian M, Dai Y, Wang R, Yamada S, Feng S, Wang Y, Chhangani D, Ou T, Li W, Guo X, McAdow J, Rincon-Limas DE, Yin X, Tai W, Cheng G, Johnson A. Infection and chronic disease activate a systemic brain-muscle signaling axis that regulates muscle function.Science Immunology. July 12, 2024.
Funding: This work is supported by the National Institutes of Health (NIH), grant numbers R01 AR070299 and R01AG059871; the National Key Research and Development Plan of China, grant numbers 2021YFC2302405, 2021YFC2300200, 2022YFC2303200, 2022YFC2303400 and 2022YFE0140700; the National Natural Science Foundation of China, grant numbers 32188101, 82271872, 32100755, 32172940 and 82341046; the Shenzhen San-Ming Project for Prevention and Research on Vector-borne Diseases, grant number SZSM202211023; the Yunnan Provincial Science and Technology Project at Southwest United Graduate School, grant number 202302AO370010; the New Cornerstone Science Foundation through the New Cornerstone Investigator Program; the Xplorer Prize from Tencent Foundation; the Natural Science Foundation of Heilongjiang Province, grant number JQ2021C005; the Science Fund Program for Distinguished Young Scholars (Overseas); and the Shenzhen Bay Laboratory Startup Fund, grant number 2133011.
Author: Jessica Church Source: WUSTL Contact: Jessica Church WUSTL Image: The image is credited to Neuroscience News
Original Research: Closed access. Infection and chronic disease activate a systemic brain-muscle signaling axis by Aaron Johnson et al. Science Immunology
Abstract
Infection and chronic disease activate a systemic brain-muscle signaling axis
Infections and neurodegenerative diseases induce neuroinflammation, but affected individuals often show nonneural symptoms including muscle pain and muscle fatigue. The molecular pathways by which neuroinflammation causes pathologies outside the central nervous system (CNS) are poorly understood.
We developed multiple models to investigate the impact of CNS stressors on motor function and found thatEscherichia coliinfections and SARS-CoV-2 protein expression caused reactive oxygen species (ROS) to accumulate in the brain. ROS induced expression of the cytokine Unpaired 3 (Upd3) inDrosophilaand its ortholog, IL-6, in mice.
CNS-derived Upd3/IL-6 activated the JAK-STAT pathway in skeletal muscle, which caused muscle mitochondrial dysfunction and impaired motor function. We observed similar phenotypes after expressing toxic amyloid- (A42) in the CNS.
Infection and chronic disease therefore activate a systemic brain-muscle signaling axis in which CNS-derived cytokines bypass the connectome and directly regulate muscle physiology, highlighting IL-6 as a therapeutic target to treat disease-associated muscle dysfunction.
See the article here:
Infection Brain Inflammation Triggers Muscle Weakness - Neuroscience News
- Neuroscience helps explain the teenage brain and mental health - ABC News - September 15th, 2024 [September 15th, 2024]
- XX Marks the Spot: Addressing Sex Bias in Neuroscience - The Scientist - September 15th, 2024 [September 15th, 2024]
- Neuroscience-based tools for transformative leadership - Fast Company - September 15th, 2024 [September 15th, 2024]
- How 100 Years of EEG Have Transformed Neuroscience - Being Patient - September 15th, 2024 [September 15th, 2024]
- Reconstructing dopamines link to reward - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- The neuroscience of itch in relation to transdiagnostic psychological approaches - Nature.com - September 15th, 2024 [September 15th, 2024]
- A README for open neuroscience - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- Dopamine and the need for alternative theories - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- Kim Stachenfeld on the dance between neuroscience and artificial intelligence - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- Vijay Mohan K. Namboodiri - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- Varied Cognitive Training Boosts Learning and Memory - Neuroscience News - September 15th, 2024 [September 15th, 2024]
- Issue | September 2024 | XX Marks the Spot: Addressing Sex Bias in Neuroscience - The Scientist - September 15th, 2024 [September 15th, 2024]
- The Transmitter Partners With World Wide Neuro and Brain Inspired, Building on Mission to Inform, Connect Neuroscience Community - StreetInsider.com - September 15th, 2024 [September 15th, 2024]
- Gene Therapy Offers Hope for Glaucoma and AMD - Neuroscience News - September 15th, 2024 [September 15th, 2024]
- The Neuroscience of Phantom Sensations: Can We Feel Whats Not Really There? - SciTechDaily - September 2nd, 2024 [September 2nd, 2024]
- Tau May Protect Brain Cells from Oxidative Damage - Neuroscience News - September 2nd, 2024 [September 2nd, 2024]
- Scientists use fainting to uncover new insights into the neuroscience of consciousness - PsyPost - September 2nd, 2024 [September 2nd, 2024]
- Biosensors and being fearless with Lin Tian - The Transmitter: Neuroscience News and Perspectives - September 2nd, 2024 [September 2nd, 2024]
- Can Neuroscience Train Your Brain to Be Happier? This Startup Has an App for That - Inc. - September 2nd, 2024 [September 2nd, 2024]
- Neuroscience Surprise: Different Types of Love Light Up Different Parts of the Brain - SciTechDaily - September 2nd, 2024 [September 2nd, 2024]
- Second paper from lab of Nobel Prize winner to be retracted - The Transmitter: Neuroscience News and Perspectives - September 2nd, 2024 [September 2nd, 2024]
- How cognitive bias affects your draft strategy with neuroscience professor Dr. Renee Miller - Yahoo Sports - August 5th, 2024 [August 5th, 2024]
- This 3-step approach to performance reviews uses neuroscience to make them less awful - Fast Company - August 5th, 2024 [August 5th, 2024]
- Is it time to worry about brain chimeras? - The Transmitter: Neuroscience News and Perspectives - August 5th, 2024 [August 5th, 2024]
- Sharing brain images can foster new neuroscience discoveries - American Heart Association - July 26th, 2024 [July 26th, 2024]
- Latest News: Neuroscience Major Applies What Shes Learned in the Classroom and in the Lab - Muhlenberg College - July 26th, 2024 [July 26th, 2024]
- BioIVT to Highlight its Integral Role in Drug and Diagnostic Discovery and Development in addition to Neuroscience Research at Premier Life Science... - July 26th, 2024 [July 26th, 2024]
- Alto Neuroscience Receives Funding Award from Wellcome Trust to Accelerate Development of ALTO-100 in Bipolar Depression Leveraging Precision... - July 26th, 2024 [July 26th, 2024]
- Neuroscience Says 3 Simple Steps Can Turn Disappointment and Stress Into Success and Fulfillment (and Boost Your Emotional Intelligence) - Inc. - July 26th, 2024 [July 26th, 2024]
- Golf: neuroscience reveals the secrets of better putting new study - The Conversation - July 26th, 2024 [July 26th, 2024]
- The Neuroscience Behind Video: Why Video is the Most Effective Marketing Channel - StreamTV Insider - July 26th, 2024 [July 26th, 2024]
- Building an autism research registry: Q&A with Tony Charman - The Transmitter: Neuroscience News and Perspectives - July 26th, 2024 [July 26th, 2024]
- Adjusting Proteins Increases Ozempics Effectiveness - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Low-Calorie Diets Harm Athletes Performance and Health - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Reflective Thinking Boosts Teen Brain Resilience to Violence - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Neuroscience Says Olympians Like Simone Biles Use the Autopilot Trick to Achieve Peak Performance. So Can You - Inc. - July 18th, 2024 [July 18th, 2024]
- What well-being is (and isnt), according to neuroscience - Big Think - July 18th, 2024 [July 18th, 2024]
- Brain Areas Take Micro-Naps While the Rest Stays Awake - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Persistent protein pairing enables memories to last - The Transmitter: Neuroscience News and Perspectives - July 18th, 2024 [July 18th, 2024]
- AI Enhances Story Creativity but Risks Reducing Novelty - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Alto Neuroscience, Inc. (NYSE:ANRO) Receives Average Rating of Buy from Analysts - Defense World - July 18th, 2024 [July 18th, 2024]
- 2024 Kavli Prize awarded for research on face-selective brain areas - The Transmitter: Neuroscience News and Perspectives - June 18th, 2024 [June 18th, 2024]
- Unlocking Flow: The Neuroscience of Creative Bliss - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- Revolutionizing Glioblastoma Treatment - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- Decoding spontaneous thoughts from the brain via machine learning - EurekAlert - April 15th, 2024 [April 15th, 2024]
- Reducing Toxic AI Responses - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- Advancing the neuroscience of human pregnancy - Nature.com - April 15th, 2024 [April 15th, 2024]
- Angela Bryan Awarded Hazel Barnes Prize | Psychology and Neuroscience - University of Colorado Boulder - April 15th, 2024 [April 15th, 2024]
- How Old Are You in Your Head? The Neuroscience of Subjective Age Reveals How to Stay Mentally Young - Inc. - April 15th, 2024 [April 15th, 2024]
- Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of ... - PR Newswire - April 15th, 2024 [April 15th, 2024]
- Those Who Use Willpower Deemed More Trustworthy - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- How Sex and Gender Shape Our Cognition - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- War's Toll on the Brain: Widespread PTSD and Anxiety Among Ukrainians - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- Paints and Pesticides Linked to ALS Risk - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- AI STORIES: A New Vision for AI and Narratives - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- Neuroscience Breakthrough Unveils How We Learn and Remember - SciTechDaily - April 15th, 2024 [April 15th, 2024]
- Pregnancy's Toll: Accelerated Aging in Young Mothers - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- Learning and Memory Formation's Molecular Basis - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- Acetaminophen in Pregnancy Not Linked to Autism, ADHD Risk - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- Childhood Loneliness Linked to Later Psychosis - Neuroscience News - April 15th, 2024 [April 15th, 2024]
- Vigil Neuroscience, Inc. (NASDAQ:VIGL) Expected to Post Q1 2024 Earnings of ($0.58) Per Share - Defense World - March 29th, 2024 [March 29th, 2024]
- International Brain Research Organisation (IBRO) Diversity Grants 2024 Opportunity Desk - Opportunity Desk - March 29th, 2024 [March 29th, 2024]
- Hereditary Alzheimer's Transmitted Via Bone Marrow Transplants - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Household Chemicals Linked to Brain Health Risks - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Cheers to Longevity: Couples Who Drink Together, Live Longer - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Sleeplessness Makes You Feel Up To Ten Years Older - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Aging Brain Cells Have Prolonged Death Process - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Anxiety Drives Wishful Thinking to Risky Levels - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Prolonged Progestogen Use Linked to Brain Tumor Risk - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- The Genetic Secrets of Neuron Formation - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Yahoo Finance - March 29th, 2024 [March 29th, 2024]
- Big research, little time: Medical neuroscience student wins 3 Minute Thesis finals - Dal News - March 29th, 2024 [March 29th, 2024]
- The new NeuroAI - Nature.com - March 29th, 2024 [March 29th, 2024]
- Exploring Aphantasia: The Mind Without a Mental Picture - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Altered Brain pH Linked to Cognitive Disorders - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Emotion vs. Reason: Rethinking Decision-Making - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- DNA Damage and Inflammation Key to Memory Formation - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Embracing Neurodiversity: Beyond Stigma to Strength - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Devil in the Details: The Visual World of Prosopometamorphopsia - Neuroscience News - March 29th, 2024 [March 29th, 2024]
- Rockefeller Neuroscience Institute receives $2M grant for ultrasound drug addiction treatments - Health Imaging - March 29th, 2024 [March 29th, 2024]